Liquid-based endometrial cytology: Cyto-histological correlation in a population of 917 women

Cytopathology

Volumn 18, Issue 4, 2007, Pages 241-249

  Buccoliero, A M ^a   Gheri, C F ^a   Castiglione, F ^a   Garbini, F ^a   Barbetti, A ^a   Fambrini, M ^a   Bargelli, G ^a   Pappalardo, S ^a   Taddei, A ^a   Boddi, V ^a   Scarselli, G F ^a   Marchionni, M ^a   Taddei, G L ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cytodiagnosis; Cytological techniques; Endometrial neoplasms; LBC; Liquid based cytology; ThinPrep; Uterine neoplasms

Indexed keywords

ADENOMYOSIS; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTODIAGNOSIS; CYTOLOGY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CELL; ENDOMETRIUM CYTOLOGY; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYSTEROSCOPY; INFORMED CONSENT; LIQUID BASED CYTOLOGY; MAJOR CLINICAL STUDY; PREDICTION AND FORECASTING; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, ENDOMETRIOID; CYTODIAGNOSIS; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; HYSTEROSCOPY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING;

EID: 34447542607     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2007.00463.x     Document Type: Article

References (47)

1. Tavassoli FA, Devilee P. Tumours of the Breast and Female Genital Organs. Pathology and Genetics. World Health Organization Classification of Tumours. Lyon, France : IARC Press 2003.
2. Jick H, Walker AM, Rothman KJ. The epidemic of endometrial cancer: a commentary. Am J Public Health 1980 70 : 264.
3. Mecklin JP, Jarvinen HJ. Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer). Cancer 1991 68 : 1109 12.
4. Esteller M, Levine R, Baylin SB, Ellenson LH, Herman JG. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene 1998 17 : 2413 7.
5. Mutter GL. Pten a protean tumor suppressor. Am J Pathol 2001 158 : 1895 8.
6. Dove-Edwin I, Boks D, Goff S et al. The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary non polyposis colorectal carcinoma and familial colorectal carcinoma. Cancer 2002 94 : 1708 12.
7. Paley PJ. Screening for the major malignancies affecting women: current guidelines. Am J Obstet Gynecol 2001 184 : 1021 30.
8. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002 11 : 1531 43.
9. Münstedt K, Grant P, Woenckhaus J, Roth G, Tinneberg HR. Cancer of the endometrium: current aspects of diagnostics and treatment. World J Surg Oncol 2004 21 : 24.
10. Bray F, Dos Santos Silva I, Moller H, Weiderpass E. Endometrial cancer incidence trends in Europe: underlying determinants and prospect for prevention. Cancer Epidemiol Biomarkers Prev 2005 14 : 1132 42.
11. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983 15 : 10 7.
12. Sherman ME. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 2000 13 : 295 308.
13. Koul A, Willen R, Bendahl PO, Nilbert M, Borg A. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis. Cancer 2002 94 : 2369 79.
14. Hui P, Kelly M, O'Malley DM, Tavassoli F, Schwartz PE. Minimal uterine serous carcinoma: a clinicopathological study of 40 cases. Mod Pathol 2005 18 : 75 82.
15. Choo YC, Mak KC, Hsu C, Wong TS, Ma HK. Postmenopausal uterine bleeding of nonorganic cause. Obstet Gynecol 1985 66 : 225 8.
16. Iatrakis G, Diakakis I, Kourounis G et al. Postmenopausal uterine bleeding. Clin Exp Obstet Gynecol 1997 24 : 157.
17. Pritchard KI. Screening for endometrial cancer: is it effective? Ann Intern Med 1989 110 : 177 9.
18. Mitchell H, Giles G, Medley G. Accuracy and survival benefit of cytological prediction of endometrial carcinoma on routine cervical smears. Int J Gynecol Pathol 1993 12 : 34 40.
19. Broso PR, Giradi F. Is it possible to screen for endometrial carcinoma? Incidence and risk factors Minerva Gynecol 1995 47 : 539 52.
20. Kim YB, Ghosh K, Ainbinder S, Berek JS. Diagnostic and therapeutic advances in gynecologic oncology: screening for gynecologic cancer. Cancer Treat Res 1998 95 : 253 76.
21. Garcia F, Barker B, Davis J et al. Thin-layer cytology and histopathology in the evaluation of abnormal uterine bleeding. J Reprod Med 2003 48 : 882 8.
22. Buccoliero AM, Caldarella A, Noci I et al. Thin layer method in endometrial cytology. Pathologica 2003 95 : 179 84.
23. Papaefthimiou M, Symiakaki H, Mentzelopoulou P et al. Study on the morphology and reproducibility of the diagnosis of endometrial lesions utilizing liquid-based cytology. Cancer Cytopathol 2005 105 : 56 64.
24. Taddei GL, Buccoliero AM. Atlante di citologia endometriale. L'endometrio normale, iperplastico e neoplastico nella citologia in fase liquida. Florence, Italy : SEE Editrice 2005.
25. De Muylder X, Neven P, De Somer M, Van Belle Y, Vanderick G, De Muylder E. Endometrial lesions in patients undergoing tamoxifen therapy. Int J Gynaecol Obstet 1991 36 : 127 30.
26. Magriples U, Naftolin F, Schwartz PE, Carcangiu ML. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol 1993 11 : 485 90.
27. Assikis VJ, Neven P, Jordan VC, Vergote I. A realistic clinical perspective of tamoxifen and endometrial carcinogenesis. Eur J Cancer 1996 32A : 1464 76.
28. Koss LG, Schreiber K, Oberlander SG, Moukhtar M, Levine HS, Moussouris HF. Screening of asymptomatic women for endometrial cancer. Obstet Gynecol 1981 57 : 681 91.
29. Archer DF, McIntyre-Seltman K, Wilborn WW et al. Endometrial morphology in asymptomatic postmenopausal women. Am J Obstet Gynecol 1991 165 : 317 22.
30. Korhonen MO, Symons JP, Hyde BM, Rowan JP, Wilborn WH. Histologic classification and pathologic findings for endometrial biopsy specimens obtained from 2964 perimenopausal ad postmenopausal women undergoing screening for continuous hormones as replacement therapy (CHART 2 Study). Am J Obstet Gynecol 1997 176 : 77 380.
31. Nagase E, Yasuda M, Kajiwara H et al. Uterine body cancer mass screening at Tokai University Hospital. Tokai J Exp Clin Med 2004 29 : 43 8.
32. Grönroos M, Salmi TA, Vuento MH et al. Mass screening for endometrial cancer directed in risk groups of patients with diabetes and patients with hypertension. Cancer 1993 71 : 1279 82.
33. De Angelis C, Santoro G, Re ME, Nofroni I. Office hysteroscopy and compliance: mini-hysteroscopy versus traditional hysteroscopy in a randomized trial. Hum Reprod 2003 18 : 2441 5.
34. Agostini A, Bretelle F, Cravello L, Maisonneuve AS, Roger V, Blanc B. Acceptance of outpatient flexible hysteroscopy by premenopausal and postmenopausal women. J Reprod Med 2003 48 : 441 3.
35. Elsandabesee D, Greenwood P. The performance of Pipelle endometrial sampling in a dedicated postmenopausal bleeding clinic. J Obstet Gynaecol 2005 25 : 32 4.
36. Bakour SH, Khan KS, Gupta JK. Controlled analysis of factors associated with insufficient sample on outpatient endometrial biopsy. Br J Obstet Gynaecol 2000 107 : 1312 4.
37. Quinn M. Screening the high risk patient for gynaecological cancer. Yonsei Med J 2002 43 : 717 21.
38. Gupta JK, Chien PF, Voit D, Clark TJ, Khan KS. Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand 2002 81 : 799 816.
39. Rascoe RR. Endometrial aspiration smear in diagnosis of malignancy of the uterine corpus. Am J Obstet Gynecol 1963 87 : 921 5.
40. An-Foraker SH, Kawada CY, McKinney D. Endometrial aspiration studies on Isaacs cell sampler with cytohistologic correlation. Acta Cytol 1979 23 : 303 8.
41. Buratti E, Cefis F, Masserini M, Goisis F, Vergadoro F, Bolis G. The value of endometrial cytology in a high risk population. Tumori 1985 28 : 71.
42. Byrne AJ. Endocyte endometrial smears in the cytodiagnosis of endometrial carcinoma. Acta Cytol 1990 34 : 373 81.
43. LaPolla JP, Nicosia S, McCurdy C et al. Experience with the EndoPap device for the cytologic detection of uterine cancer and its precursors: a comparison of the EndoPap with fractional curettage or hysterectomy. Am J Obstet Gynecol 1990 163 : 1055 60.
44. Hecht EL. The endometrial aspiration smear; research status and clinical value. Am J Obstet Gynecol 1956 71 : 819 33.
45. Caubel P, Blondon J, Foulques H, Lefranc JP. Cancer of the endometrium: epidemiology, histology, diagnostic methods. Rev Prat 1990 40 : 31 5.
46. Stovall TG, Ling FW, Morgan PL. A prospective, randomized comparison of the pipelle endometrial sampling device with the Novak curette. Am J Obstet Gynecol 1991 165 : 1287 9.
47. Minagawa Y, Sato S, Ito M, Onohara Y, Nakamoto S, Kigawa J. Transvaginal ultrasonography and endometrial cytology as a diagnostic schema for endometrial cancer. Gynecol Obstet Invest 2005 59 : 149 54.